Top Markets
#1 DogBull DogBull +107.65%
#2 MarsCoin MarsCoin +71.27%
#3 ADO Protocol ADO Protocol +51.79%
#4 Siacoin Siacoin +42.08%
#5 Ontology Gas Ontology Gas +22.87%
#6 The Bitcoin Bull The Bitcoin Bull +16.60%
#7 Apertum Apertum +14.97%
#8 Nockchain Nockchain +12.43%
#9 Useless Coin Useless Coin +12.33%
#10 UnifAI Network UnifAI Network +12.04%
Coin of the day
DogBull DogBull
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Hisse Senetlerindeki Sıralama #15114
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Hisse Fiyatı
$4.74
Son senkronizasyon: 2026-08-31
Piyasa Değeri
$372.19M
Değişim (1 gün)
-2.47%
Değişim (1 yıl)
-1.04%
Ülke
US
Ticaret Lexeo Therapeutics, Inc. Common Stock (LXEO)

Kategori

Healthcare
Lexeo Therapeutics, Inc. Common Stock (LXEO) için gelir
Sep 2026 itibarıyla gelir TTM: 0
Lexeo Therapeutics, Inc. Common Stock şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Lexeo Therapeutics, Inc. Common Stock için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH